Literature DB >> 17100152

Clinicopathological review of 61 patients with early bile duct cancer.

J M Cha1, M H Kim, S K Lee, D W Seo, S S Lee, J H Lee, S G Lee, S J Jang.   

Abstract

AIMS: The concept of early cancer is already established in the hollow viscus. However, there is no broadly accepted concept of early bile duct cancer. We aimed to assess whether early bile duct cancer patients have characteristic clinicopathological features and a better prognosis compared with patients with advanced bile duct cancer.
MATERIALS AND METHODS: Between June 1996 and December 2004, 614 patients were histologically confirmed with primary bile duct cancers after resection. Extrahepatic early bile duct cancers are defined as carcinoma where invasion is confined within the fibromuscular layer of the extrahepatic bile duct. Intrahepatic early bile duct cancers arising from intrahepatic large bile ducts are also defined as carcinoma confined within the fibromuscular layer. We retrospectively reviewed medical records to obtain demographic, laboratory, radiological and pathological data.
RESULTS: Sixty-one (10%) patients were categorised with early bile duct cancers. They were frequently detected at asymptomatic (39%) or non-icteric (84%) stages. The most common gross type was the intraductal-growing type (58%). Not otherwise specified adenocarcinoma was only 67%, whereas papillary carcinoma was 31% of cancers. No lymph node metastasis and no lymphovascular/perineural invasions were noted in 89% of patients. The 5-year survival rate for early bile duct cancer was excellent (80%).
CONCLUSIONS: Although early bile duct cancer is not a common disease, it is not a very rare entity either. The clinicopathological features of early bile duct cancer patients differ from those of advanced bile duct cancer patients, with asymptomatic clinical presentation, different macroscopic and microscopic findings, and excellent prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17100152     DOI: 10.1016/j.clon.2006.07.005

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  7 in total

1.  Is it possible to define early distal cholangiocarcinoma?

Authors:  Fumihiko Miura; Keiji Sano; Hodaka Amano; Naoyuki Toyota; Keita Wada; Takuo Tokairin; Fukuo Kondo; Koichi Hayano; Hisahiro Matsubara; Tadahiro Takada
Journal:  Langenbecks Arch Surg       Date:  2015-10-30       Impact factor: 3.445

2.  Surgical strategy for bile duct cancer: Advances and current limitations.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Daijo Hashimoto
Journal:  World J Clin Oncol       Date:  2011-02-10

3.  Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.

Authors:  Jongha Park; Myung-Hwan Kim; Kyu-Pyo Kim; Do Hyun Park; Sung-Hoon Moon; Tae Jun Song; Junbum Eum; Sang Soo Lee; Dong Wan Seo; Sung Koo Lee
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

Review 4.  Early bile duct cancer.

Authors:  Jae Myung Cha; Myung-Hwan Kim; Se Jin Jang
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

5.  Local surgical resection of hilar cholangiocarcinoma: is there still a place?

Authors:  L Capussotti; L Vigano; A Ferrero; A Muratore
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

6.  Albumin-Bilirubin Grade as a Novel Predictor of Survival in Advanced Extrahepatic Cholangiocarcinoma.

Authors:  Yong Wang; Qing Pang; Hao Jin; Lei Zhou; Xiaosi Hu; Zhen Qian; Zhongran Man; Song Yang; Huichun Liu
Journal:  Gastroenterol Res Pract       Date:  2018-12-02       Impact factor: 2.260

Review 7.  Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity.

Authors:  Rosa B Schmuck; Cynthia V de Carvalho-Fischer; Christopher Neumann; Johann Pratschke; Marcus Bahra
Journal:  Cancer Med       Date:  2015-12-09       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.